Skip to content

Saturday, October 24, 2026

Author

Dr. Nathan Pryce

Covers the biotech industry: pipelines, financing and FDA decisions.

Articles by Dr. Nathan Pryce

A scientist studies a bar-chart readout on a monitor beside racked sample tubes, cool white and teal tones across a steel lab bench.

How Biotech Financing Is Actually Structured, From Series A to IPO

Dr. Nathan Pryce